Addex Therapeutics Ltd. (ADXN) stock
ADXNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on May 15, 2026Score 0/30
$3.40+0.34 (+11.11%)
Close on Nov 19, 2026Market cap $69.81KP/E –Yield –
Addex Therapeutics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2025 it was -CHF 2.17M. The highest annual figure on record is CHF 1.75M in fiscal 2018.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -CHF 2.17M | – |
| FY2024 | Dec 31, 2024 | -CHF 5.37M | – |
| FY2023 | Dec 31, 2023 | -CHF 7.99M | – |
| FY2022 | Dec 31, 2022 | -CHF 16.44M | – |
| FY2021 | Dec 31, 2021 | -CHF 14.71M | – |
| FY2020 | Dec 31, 2020 | -CHF 12.18M | – |
| FY2019 | Dec 31, 2019 | -CHF 9.48M | -641.3% |
| FY2018 | Dec 31, 2018 | CHF 1.75M | – |
| FY2017 | Dec 31, 2017 | -CHF 2.14M | – |
See a number that looks wrong?